drugset / Trial / NCT03436836

Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract Surgery

NCT03436836

RandomizedParallel-groupDouble-blindSupportive care

Summary

Nalbuphine has been used as an adjuvant to bupivacaine in intrathecal, epidural, caudal anesthesia and peripheral nerve blocks showing an increase in the efficacy and the duration of postoperative analgesia.The aim of this study is evaluation of the effect of nalbuphine when used as an adjuvant to a local anesthetic mixture in peribulbar block undergoing cataract surgery

Timeline

Start
2018-01-14
Primary completion
2018-02-20
Completion
2018-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalbuphine Small molecule 4 mg Other
Comparator Bupivacaine Other / unclassified 4 ml Other
Comparator Lidocaine Other / unclassified 3 ml Other
Comparator rHuPH20 Protein / enzyme biologic 75 iu Other

Indications

No indication recorded.